Determinants of appropriate antibiotic and NSAID prescribing in unscheduled outpatient settings in the veterans health administration

2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. ;COPYRIGHT 2024 BioMed Central Ltd. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024 ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/s12913-024-11082-0 ;PMID: 38760660

Full text available

Heart failure subtype after acute kidney injury

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2369 ;EISSN: 1471-2369 ;DOI: 10.1186/s12882-024-03602-1 ;PMID: 38760794

Full text available

Using intervention mapping to design and implement a multicomponent intervention to improve antibiotic and NSAID prescribing

Published by Oxford University Press on behalf of the Society of Behavioral Medicine 2023. 2023 ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1869-6716 ;EISSN: 1613-9860 ;DOI: 10.1093/tbm/ibad063

Full text available

Multinational Patterns of Second-line Anti-hyperglycemic Drug Initiation Across Cardiovascular Risk Groups: A Federated Pharmacoepidemiologic Evaluation in LEGEND-T2DM

Digital Resources/Online E-Resources

Simulating complex patient populations with hierarchical learning effects to support methods development for post-market surveillance

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2288 ;EISSN: 1471-2288 ;DOI: 10.1186/s12874-023-01913-9 ;PMID: 37041457

Full text available

MULTINATIONAL PATTERNS OF SECOND-LINE ANTI-HYPERGLYCEMIC DRUG INITIATION IN ESTABLISHED CARDIOVASCULAR DISEASE: A FEDERATED PHARMACOEPIDEMIOLOGIC EVALUATION IN LEGEND-T2DM

2023 American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(23)02090-9

Full text available

Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe

2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 ;ISSN: 0277-0903 ;EISSN: 1532-4303 ;DOI: 10.1080/02770903.2021.2025392

Digital Resources/Online E-Resources

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;EISSN: 2754-0413 ;DOI: 10.1136/bmjmed-2023-000651 ;PMID: 37829182

Full text available

Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2631-4940 ;EISSN: 2631-4940 ;DOI: 10.1136/bmjsit-2021-000123 ;PMID: 36393894

Full text available

Maintaining a National Acute Kidney Injury Risk Prediction Model to Support Local Quality Benchmarking

ISSN: 1941-7713 ;EISSN: 1941-7705 ;DOI: 10.1161/CIRCOUTCOMES.121.008635 ;PMID: 35959674

Full text available

Evaluation of intervertebral body implant performance using active surveillance of electronic health records

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2631-4940 ;EISSN: 2631-4940 ;DOI: 10.1136/bmjsit-2021-000125 ;PMID: 35909993

Full text available

Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System

Springer Science+Business Media, LLC, part of Springer Nature 2021 ;2021. Springer Science+Business Media, LLC, part of Springer Nature. ;Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-021-07148-4 ;PMID: 33523335

Full text available

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease

2021 ;ISSN: 2666-6677 ;EISSN: 2666-6677 ;DOI: 10.1016/j.ajpc.2021.100300 ;PMID: 34950914

Full text available

Ankle- and Toe-Brachial Index for Peripheral Artery Disease Identification: Unlocking Clinical Data Through Novel Methods

ISSN: 1941-7640 ;EISSN: 1941-7632 ;DOI: 10.1161/CIRCINTERVENTIONS.121.011092 ;PMID: 35176872

Full text available

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

2022 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 2022 ;2022 by the American Diabetes Association 2022 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-1815 ;PMID: 35015080

Full text available

Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. 2021 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2021-057632 ;PMID: 34937726

Full text available

Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2158-3188 ;EISSN: 2158-3188 ;DOI: 10.1038/s41398-021-01760-6 ;PMID: 34930903

Full text available

Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0307-0565 ;EISSN: 1476-5497 ;DOI: 10.1038/s41366-021-00893-4 ;PMID: 34267326

Full text available

Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-99481-9 ;PMID: 34642371

Full text available

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1038 ;PMID: 33975825

Full text available